RESULTS

Worldwide incidence and mortality prevalence
Worldwide melanoma accounts for 4% of cancer diagnoses, yet represents 75% of skin cancer-related deaths (2), with incidence and death rates increas ing globally over the past few decades (3, 4) . The fiveyear survival rate for pa tients with advanced melanoma and dis tant metastatic disease is 10% (5) . Mela noma occurs in slightly more women than men, but mortality rates are higher for men (4) . It has been observed (6) that a higher case fatality rate for melanoma has been reported in lowerincome areas of the world (57.5%) compared with higherincome areas (16.3%). Poor mela noma survival rates have been observed in patients with low socioeconomic sta tus (7) as well as those aged 65 years and older who resided in lowerincome areas (8) .
Global risk factors
Several studies (9) (10) (11) (12) (13) (14) identified certain variables associated with an increased risk of developing melanoma: European ancestry, blonde and red hair, fair skin tone, lightcolored eyes, the presence of freckles and/or melanocytic nevi, and family history of malignant melanoma. Other highrisk variables include a his tory of sunburns (14) , a high number of lifetime burns (15) , intermittent sun ex posure, and more frequent skin exposure (10, 11) . Some evidence (13) suggests that sunburn before the age of 15 years may increase the risk of developing cutane ous melanoma (odds ratio, 2.4). How ever, a large metaanalysis showed the risk of melanoma may increase with the cumulative number of sunburns expe rienced during all periods of life (child hood, adolescence, and adulthood) and not just those experienced at a young age (15) . Additional data on sun expo sure throughout the lifespan are needed to further understand its effect on the development of melanoma, especially in Latin America.
Country-specific incidence and mortality prevalence
Few clinical and histopathological data on patients with melanoma are available for each Latin American country stud ied. True incidence data are scant and generally obtained from small, single institution or casecontrol studies that hinder comparative evaluation (16) . The following section describes the available epidemiological data related to mela noma incidence and mortality rates in Argentina, Brazil, Colombia, Mexico, Puerto Rico, and Venezuela. (19) examined a total of 3 832 melanoma cases that were registered in the RAMC over a six year period. The most frequent primary tumor site was the lower extremities (for women) and the trunk (for men). Patients who received their diagnosis and treatment from public health care facilities had thicker primary tumors than those who were treated at private health care centers.
Argentina
In an analysis of death certifica tion data nationwide, overall cutane ous melanoma ageadjusted mortality rates for the period from 1997 to 2001 were 1.1 per 100 000 in males and 0.6 per 100 000 in females (20) . Argentina's melanoma mortality rates are hetero geneous, mainly because variation in skin color prevalence across different regions results in different incidence rates. For example, in the two northern provinces of Salta and Tucumán, which have a high prevalence of people of indigenous descent who have darker skin, ageadjusted mortality rates due to melanoma in men were 0.1 and 0.3 per 100 000 respectively (1997) (1998) (1999) (2000) (2001) (20 (31) . The mean age at presentation for melanoma has been reported as 58 years and the survival rate has been shown to be lower among the black population from the Pacific Region, partly due to delayed diagnoses (32) .
Mexico.
In 2003, the most recent year for which data are available, Mexico's Histopathologic Cancer Registry (Registro Histopatológico de Neoplasias Malignas, RHNM) reported a total of 14 319 cases of skin cancer, of which 9.02% (1 293 new cases) corresponded to melanoma (33) . Melanoma mortality represented 377 cases or 0.4 per 100 000 inhabi tants (34) . The latest report from the Melanoma Clinic at Mexico's National Cancer Institute (Instituto Nacional de Cancerología, INCan) (35) noted that in cidence of melanoma increased during 1990 to 2004, and was more prevalent in women (57.1%), and the mean age at presentation was 54.3 years. Ruiz Maldonado et al. (36) analyzed four hospitalbased studies that revealed the most common primary tumor site was the lower extremities. Additional publi cations support these findings (37) .
Puerto Rico. A retrospective study of all melanoma cases reported to the Puerto Rico Central Cancer Registry (El Registro Central de Cáncer de Puerto Rico, PRCCR) from 1987 to 2002 (38) revealed 1 568 new melanoma cases, with a mean of 98 new cases per year. The annual ageadjusted incidence and mortality rates were 1.9 (men) to 3.6 (women) and 0.3 (men) to 0.7 (women) respectively per 100 000 inhabitants. The majority of reported cases among both men and women were 61 to 80 years of age, with an equal percentage of men and women affected. Consistent with what was seen in other Latin American countries, the most common anatomical location was the lower extremities (in women) and the trunk (in men).
Venezuela. To date, there are few pop ulationbased studies reporting mela noma incidence rates and no reliable reg istry data reporting melanoma mortality rates for Venezuela (39, 40 (41), there were 701 patients in the database; of these, 54.9% were women, and the median age of presentation was 56 years. The annual reported number of skin cancer cases was 116. Fiftyseven percent (57%) of the patients with melanoma had a previous history of sunburn. The most frequent localization site for primary melanoma was the limbs (53.2%), fol lowed by the trunk (32%) and the head and neck areas (14.8%). Most cases were recorded as invasive melanoma (84.4%).
Geography-and patient-related risk factors
Although consistent data related to the incidence, prevalence, and mortal ity rates of melanoma are lacking in Latin America, the risk of developing melanoma appears to be associated Venezuela. Venezuela is a country of great racial diversity. The majority of the current population is mestizo, with the remainder mainly of European (primar ily German, Italian, Portuguese, or Span ish) descent (50) . Blacks account for an estimated 8% to 10% of the population, and Amerindians represent about 2%. Arabs also represent part of the over all populace (50) . Based on data from GMMM (41), the majority of patients with melanoma had fair skin tone and lightcolored eyes, and those with light skin had relatively high levels of pig mentation (skin phototype III).
Environmental variables related to disease burden
Dramatic changes in the Earth's ozone have been reported since the late 1980s (51) . In the Southern Hemisphere, the increase in ultraviolet (UV) radiation has been estimated at 5% per decade at 30 degrees south to 40% per decade at 85 degrees south (51) . Fifteen percent (15%) of the ozone layer has been depleted over the southern end of South America during the past 15 years, and an increase of up to 85% in UVB radiation in the southern part of Chile has been observed (52, 53). Corrêa et al. (54) reported that cities in highaltitude areas are at risk for dangerous levels of exposure to UV radiation. For each 1 000meter increase in altitude, UV radiation increases by 6% to 8%. Many populated areas in Latin America are at higher elevations (e.g., La Paz, Bolivia, the highestaltitude capital city in the world, and São Paulo, Brazil, one of the most highly populated cities in South America). Furthermore, in re cent decades, it has been observed (55) that the use of ozonedestroying chemi cals has caused the thinning of the ozone layer, which worsens the effects of sun overexposure. In the Southern Hemi sphere, the ozone layer normally thins each spring. Several reports (52, 55) have noted that ozone depletion in an area above the southern portion of Argentina and Chile causes a 25% increase in UV radiation exposure during this time of the year. UV radiation in the Southern Hemisphere is expected to worsen in the coming decades due to natural varia tions in the amount of ozone circulat ing in the upper atmosphere (52) . In Antarctica, the hole in the Earth's ozone layer expanded to 27.5 million km 2 in September 2006 (55) . A greater incidence of cutaneous melanoma has been found among populations living under the Antarctic ozone hole (southern Chile) and in the south of Brazil (54, 56) com pared to people who live in regions where there is no ozone hole (20) or only reside in ozonedepleted areas during seasons of the year when the ozone hole is smaller (56) . Although the causality of this relationship cannot be determined because these studies did not control for confounding variables, the evidence Schmerling et al. • Cutaneous melanoma in Latin America: the need for more data Original research supports the link between increased UV exposure and increased melanoma risk.
Health care limitations affecting disease burden
Variables in delay of melanoma diagnosis. Despite the known risks of overexposure to UV rays, several au thors (57, 58) have reported the common worldwide view that tanned skin is at tractive, healthy, and protects against future burns. Many individuals do not view intentional tanning outdoors or at indoor tanning booths as a health risk (57, 58) . In fact, there is a relatively high frequency of sunbathing and tanning bed use among youth (58, 59) . A popula tionbased, crosssectional study of 1 412 Brazilians aged 10 to 29 years (60) found that nearly half of the patients enrolled in the study were sunburned in the past year. A similar study of 3 136 Brazilian adults (61) found that individuals who had the greatest sun exposure were the least likely to use sunscreen. Sunscreen users were typically female, Caucasian, and had a high level of education or high socioeconomic status. In many parts of Latin America, geo graphic or financial constraints can im pede patient access to basic health care. Frequent visits to the physician increase the likelihood that patients will be di agnosed with melanoma at an early stage-when the lesions are still thin (62) . However, access to health care in many regions of Latin America is often limited (24, 33, 45) . Villegas et al. (45) examined a mixed population from the Andean region in Colombia and con cluded that patients experienced a me dian time of 243.5 days between lesion detection and evaluation by a derma tologist. Delayed melanoma diagnosis was associated with being female, older than 65 years of age, and living in a rural setting. In Argentina, González et al. reported that patients without pri vate health insurance and those without any health insurance were more likely to be diagnosed with more advanced stages of melanoma. 7 Studies in other regions have shown that socioeconomic status influences diagnosis time for a variety of medical conditions. The racial and geographic diversity of the Latin American population makes establish ing a similar correlation difficult. This correlation should be studied in future research.
Knowledge of melanoma.
Knowledge about the importance of early detection varies worldwide. A study by Blum et al. (63) assessed factors that delay diag nosis in Australia, Brazil, Germany, and Sweden. Investigators found that about 62% of patients from Brazil detected the lesion themselves, a higher percentage than that found in other countries (52%-59%). Overall, more women than men detected lesions on their own. Compared with the other countries, people in Brazil had the lowest awareness of the impor tance of early detection (63) . Further more, most people from Brazil received their knowledge about melanoma from the media, with few citing physicians as their source of information, and an even smaller number citing prevention campaigns.
Although official (national) public health policies for melanoma diagnosis and treatment have been published in most countries in the region, the infor mation contained within them varies, re sulting in inconsistent public awareness messages regarding melanoma.
Regional melanoma management and awareness
Melanoma awareness initiatives (i.e., screening and detection campaigns) have shown varying degrees of success and acceptance in countries that showed an increase in the incidence of skin can cer over the past decade (64) (65) (66) (67) . In some Latin American countries, private non profit organizations such as Venezuela's Anticancer Society (Sociedad Anticancerosa de Venezuela, SAV), the CDFLLA in Colombia, the Brazilian Society of Dermatology (Sociedade Brasileira de Dermatologia, SBD), and the FCP and SAD in Argentina are key players in carrying out annual nationwide melanoma detec tion campaigns (64) (65) (66) 68) . For the past 17 years, the SAD has held annual mela noma detection campaigns, with a yearly increase in attendance. In Brazil, in 2008, more than 40 000 people attended the an nual National Campaign to Prevent Skin Cancer (Campanha Nacional de Prevenção do Câncer da Pele), and skin lesions were found in 10% of attendees (66) .
Screening for melanoma is a contro versial topic because its effectiveness in increasing survival has not been estab lished (69) . Consequently, governments and other agencies may not be willing to invest in widespread screening cam paigns. However, mass media screening campaigns have been found useful in targeting highrisk groups. Thus, ad ditional efforts would invariably aid in advanced melanoma management (69) .
DISCUSSION
To the best of the authors' knowledge, this is the first literature review to sum marize the published and available mela noma incidence and mortality data for the Latin American countries of Argentina, Brazil, Colombia, Mexico, Puerto Rico, and Venezuela. The importance of re porting the true incidence and mortality rates of melanoma cannot be overstated. Argentine, Brazilian, and Puerto Rican specialists have conducted more studies that report incidence data compared with researchers in the three other countries. Mexico, Venezuela, and Colombia have performed only a few populationbased or casecontrol studies describing mela noma in their populations.
Cancer registries are essential for col lecting and gathering accurate epidemio logical information related to melanoma. All six countries have cancer registries that, to some degree, regularly collect and report new cases of melanoma. How ever for the most part, the data from the countryspecific cancer registries are lim ited in terms of the variables collected, are regionalized, and represent only a small fraction of the actual melanoma incidence rates, as many people remain ing undiagnosed. Although melanoma mortality rates are usually captured and reported in these registries, the data collection is not efficient, and there is no standard method of collection, mak ing comparisons between regions and countries difficult. While dermatological societies and multidisciplinary academic groups have encouraged specialists to enter melanoma data in their databases, this information represents only a small fraction of true melanoma incidence in the general population of each country. In addition, investigators and research ers have limited resources and therefore have not published a sufficient amount of data for local and international ap praisal. The main impediments to es tablishing and maintaining an accurate epidemiological database for the coun tries studied in this review are under reporting of melanoma and the lack of a centralized collection system. Legislation tailored to each country's specific type of health system could help researchers obtain more accurate epidemiological data. Each country has unique needs and challenges in containing melanoma, and much work is needed to improve outcomes.
The lack of reliable epidemiological data for Latin America limits the degree of melanoma awareness in the region. Having an accurate, centralized mela noma registry could facilitate more effec tive educational programs and improve health care planning. Additional studies elucidating the etiology and risk factors for melanoma among minority popula tions are also warranted. Unfortunately, the heterogeneity of the health care sys tems in Latin American countries makes it difficult to establish a supranational cooperative system for data gathering in melanoma as well as other diseases.
People in certain strata of Latin Ameri can populations appear to have a greater awareness of melanoma than others (45) . Increased awareness (along with changes in the registration process) may help ex plain the recent increase in melanoma cases shown in some of the country specific cancer registries. Awareness campaigns are best targeted to those with limited access to health care, who would benefit the most.
As melanoma treatment evolves, Latin American governments and regulatory health care agencies will face the chal lenge of adjusting policies and reim bursement guidelines to allow patient access to better care. Key policymakers must recognize melanoma as a serious cancer and give priority to melanoma management.
Limitations
This review was limited by the small amount of published and available in cidence and mortality data for Latin America. In addition, the data derived from the cancer registries were relatively sparse, may not be representative of the general population, and covered only short periods, and a large proportion of the information obtained in the literature review came from studies conducted in hospitals, health care facilities and institutions, and cancer registries with different methods of data collection and no uniformity in data reporting, which hindered comparative evaluation and precluded meaningful statistical analy sis. Finally, in an attempt to cover a larger geographic area and compare dif ferent strategies across the region (with less discrepancies in terms of methodol ogy and technical resources), the authors limited the first and second search peri ods to the years 2000 through 2009 and 2010 respectively.
Conclusion
Melanoma is a serious and lifethreat ening public health problem in Latin America. Although attempts have been made to collect melanoma epidemiologic data for Latin American countries and disseminate information about the risk factors, these efforts are not yet sufficient. Environmental factors such as the effects of the ozone layer and individual factors such as mixed ethnicity could be better explored and compared with other re gions of the world if solid epidemiologi cal data were available. These data could also facilitate improvements in health care planning. Increased melanoma aware ness could lead to better health care for individuals as well as the general popula tions of countries in the region.
Objetivo. Identificar la literatura científica sobre el melanoma cutáneo en América Latina y recopilar todos los datos epidemiológicos disponibles, con objeto de demos trar la necesidad de información fiable a escala regional y de país sobre los datos de incidencia y mortalidad. Métodos. Se realizaron búsquedas bibliográficas en las bases de datos PubMed, Em base, LILACS y Google Scholar para encontrar estudios epidemiológicos relacionados con el melanoma llevados a cabo del 1 de enero del 2000 al 31 de octubre del 2010 en Argentina, Brasil, Colombia, México, Puerto Rico y Venezuela. Se efectuó una bús queda final de casos de melanoma mediante la consulta de los registros poblacionales de cáncer de cada país. No se realizó ningún análisis estadístico. Resultados. En los seis países, la mayor parte de la investigación epidemiológica sobre el melanoma cutáneo consiste en estudios hospitalarios o estudios de casos y testigos. Muy pocos estudios informan sobre las tasas de incidencia y mortalidad. Los intentos de calcular las tasas de la enfermedad se han basado en los datos nacionales de incidencia y mortalidad, y en la información extraída de los registros de cáncer. Aunque el predominio de la ascendencia europea constituye un conocido factor de riesgo de melanoma, la asociación entre el melanoma y el grupo étnico no puede de mostrarse adecuadamente en algunas de las poblaciones estudiadas. Los latinoameri canos están frecuentemente expuestos a la radiación ultravioleta como consecuencia del clima tropical, la elevada altitud y la disminución de la capa de ozono en algunas regiones. La piel bronceada se considera como saludable y bella. Aunque hace de cenios que se llevan a cabo campañas de salud pública dedicadas al melanoma en América Latina, es indispensable incrementar la conciencia de esta enfermedad. Conclusiones. Existe la urgente necesidad de recopilar datos epidemiológicos pre cisos sobre el melanoma en América Latina. Las futuras actividades de investigación en la Región deben incluir un mayor número de estudios poblacionales extensos y específicos de cada país, que permitan evaluar comparativamente las tasas de inci dencia y mortalidad.
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